CLOSING THE MEDICARE PART D COVERAGE GAP- TRENDS IN DRUG UTILIZATION AND EXPENDITURES, 2008- 2015

Author(s)

Park J, Look KA
University of Wisconsin-Madison, Madison, WI, USA

OBJECTIVES: Under the Affordable Care Act (ACA), the Medicare Part D coverage gap has been phasing out gradually since 2011. This study analyzes trends in prescription drug utilization and expenditures from 2008 to 2015.

METHODS: Data on non-disabled Part D seniors who did not receive the Low-Income Subsidy were obtained from the 2008-2015 Medicare Current Beneficiary Survey. Drug utilization was measured using the mean annual number of 30-day prescription drug fills per person. Drug expenditures were measured at two levels: mean annual total and out-of-pocket spending per person. All analyses were conducted separately for four different populations: all beneficiaries, those not reaching the coverage gap, those entering the coverage gap without reaching the catastrophic threshold, and those reaching the catastrophic threshold.

RESULTS: Overall, the use of prescription drugs increased after the ACA, although no significant changes were among those reaching the catastrophic threshold. Total drug spending steadily increased after the ACA except for those not reaching the coverage gap; the largest increase was among those reaching the catastrophic threshold (43% increase from 2009 to 2015). However, out-of-pocket drug spending significantly decreased in the post-ACA period with the largest decrease in those not entering the coverage gap. For those reaching the catastrophic threshold, out-of-pocket spending incurred during the catastrophic coverage phase significantly increased.

CONCLUSIONS: Despite increasing utilization and total costs of prescription drugs after the ACA, out-of-pocket drug costs significantly decreased. Our findings provide evidence the ACA’s coverage gap reform has helped to reduce financial barriers to prescription drugs for Part D beneficiaries. However, the findings of substantial increases in total drug spending over time, especially among those reaching the catastrophic threshold, may indicate a growing burden on the Medicare program. Potential changes to the Part D program and drug pricing models may be needed to reduce the growing total spending.

Conference/Value in Health Info

2019-05, ISPOR 2019, New Orleans, LA, USA

Value in Health, Volume 22, Issue S1 (2019 May)

Code

PDG58

Topic

Economic Evaluation, Health Policy & Regulatory

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies, Public Spending & National Health Expenditures

Disease

Geriatrics

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×